Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition

Marco Cordani, Elisa Oppici, Ilaria Dando, Elena Butturini, Elisa Dalla Pozza, Mercedes Nadal-Serrano, Jordi Oliver, Pilar Roca, Sofia Mariotto, Barbara Cellini, Giovanni Blandino, Marta Palmieri, Silvia Di Agostino, Massimo Donadelli

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Mutations in TP53 gene play a pivotal role in tumorigenesis and cancer development. Here, we report that gain-of-function mutant p53 proteins inhibit the autophagic pathway favoring antiapoptotic effects as well as proliferation of pancreas and breast cancer cells. We found that mutant p53 significantly counteracts the formation of autophagic vesicles and their fusion with lysosomes throughout the repression of some key autophagy-related proteins and enzymes as BECN1 (and P-BECN1), DRAM1, ATG12, SESN1/2 and P-AMPK with the concomitant stimulation of mTOR signaling. As a paradigm of this mechanism, we show that atg12 gene repression was mediated by the recruitment of the p50 NF-κB/mutant p53 protein complex onto the atg12 promoter. Either mutant p53 or p50 NF-κB depletion downregulates atg12 gene expression. We further correlated the low expression levels of autophagic genes (atg12, becn1, sesn1, and dram1) with a reduced relapse free survival (RFS) and distant metastasis free survival (DMFS) of breast cancer patients carrying TP53 gene mutations conferring a prognostic value to this mutant p53-and autophagy-related signature. Interestingly, the mutant p53-driven mTOR stimulation sensitized cancer cells to the treatment with the mTOR inhibitor everolimus. All these results reveal a novel mechanism through which mutant p53 proteins promote cancer cell proliferation with the concomitant inhibition of autophagy.

Original languageEnglish
JournalMolecular Oncology
DOIs
Publication statusAccepted/In press - Dec 1 2015

Fingerprint

Mutant Proteins
p53 Genes
Autophagy
Breast Neoplasms
Neoplasms
Mutation
AMP-Activated Protein Kinases
Survival
Lysosomes
Pancreatic Neoplasms
Genes
Carcinogenesis
Down-Regulation
Cell Proliferation
Neoplasm Metastasis
Gene Expression
Recurrence
Enzymes
Therapeutics

Keywords

  • AMPK
  • Autophagy
  • Cancer
  • Gain-of-function
  • MTOR
  • Mutant p53

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Medicine

Cite this

Cordani, M., Oppici, E., Dando, I., Butturini, E., Dalla Pozza, E., Nadal-Serrano, M., ... Donadelli, M. (Accepted/In press). Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition. Molecular Oncology. https://doi.org/10.1016/j.molonc.2016.04.001

Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition. / Cordani, Marco; Oppici, Elisa; Dando, Ilaria; Butturini, Elena; Dalla Pozza, Elisa; Nadal-Serrano, Mercedes; Oliver, Jordi; Roca, Pilar; Mariotto, Sofia; Cellini, Barbara; Blandino, Giovanni; Palmieri, Marta; Di Agostino, Silvia; Donadelli, Massimo.

In: Molecular Oncology, 01.12.2015.

Research output: Contribution to journalArticle

Cordani, M, Oppici, E, Dando, I, Butturini, E, Dalla Pozza, E, Nadal-Serrano, M, Oliver, J, Roca, P, Mariotto, S, Cellini, B, Blandino, G, Palmieri, M, Di Agostino, S & Donadelli, M 2015, 'Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition', Molecular Oncology. https://doi.org/10.1016/j.molonc.2016.04.001
Cordani, Marco ; Oppici, Elisa ; Dando, Ilaria ; Butturini, Elena ; Dalla Pozza, Elisa ; Nadal-Serrano, Mercedes ; Oliver, Jordi ; Roca, Pilar ; Mariotto, Sofia ; Cellini, Barbara ; Blandino, Giovanni ; Palmieri, Marta ; Di Agostino, Silvia ; Donadelli, Massimo. / Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition. In: Molecular Oncology. 2015.
@article{3b3cacea6dc94230bd66f07343dd0659,
title = "Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition",
abstract = "Mutations in TP53 gene play a pivotal role in tumorigenesis and cancer development. Here, we report that gain-of-function mutant p53 proteins inhibit the autophagic pathway favoring antiapoptotic effects as well as proliferation of pancreas and breast cancer cells. We found that mutant p53 significantly counteracts the formation of autophagic vesicles and their fusion with lysosomes throughout the repression of some key autophagy-related proteins and enzymes as BECN1 (and P-BECN1), DRAM1, ATG12, SESN1/2 and P-AMPK with the concomitant stimulation of mTOR signaling. As a paradigm of this mechanism, we show that atg12 gene repression was mediated by the recruitment of the p50 NF-κB/mutant p53 protein complex onto the atg12 promoter. Either mutant p53 or p50 NF-κB depletion downregulates atg12 gene expression. We further correlated the low expression levels of autophagic genes (atg12, becn1, sesn1, and dram1) with a reduced relapse free survival (RFS) and distant metastasis free survival (DMFS) of breast cancer patients carrying TP53 gene mutations conferring a prognostic value to this mutant p53-and autophagy-related signature. Interestingly, the mutant p53-driven mTOR stimulation sensitized cancer cells to the treatment with the mTOR inhibitor everolimus. All these results reveal a novel mechanism through which mutant p53 proteins promote cancer cell proliferation with the concomitant inhibition of autophagy.",
keywords = "AMPK, Autophagy, Cancer, Gain-of-function, MTOR, Mutant p53",
author = "Marco Cordani and Elisa Oppici and Ilaria Dando and Elena Butturini and {Dalla Pozza}, Elisa and Mercedes Nadal-Serrano and Jordi Oliver and Pilar Roca and Sofia Mariotto and Barbara Cellini and Giovanni Blandino and Marta Palmieri and {Di Agostino}, Silvia and Massimo Donadelli",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.molonc.2016.04.001",
language = "English",
journal = "Molecular Oncology",
issn = "1574-7891",
publisher = "Elsevier",

}

TY - JOUR

T1 - Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition

AU - Cordani, Marco

AU - Oppici, Elisa

AU - Dando, Ilaria

AU - Butturini, Elena

AU - Dalla Pozza, Elisa

AU - Nadal-Serrano, Mercedes

AU - Oliver, Jordi

AU - Roca, Pilar

AU - Mariotto, Sofia

AU - Cellini, Barbara

AU - Blandino, Giovanni

AU - Palmieri, Marta

AU - Di Agostino, Silvia

AU - Donadelli, Massimo

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Mutations in TP53 gene play a pivotal role in tumorigenesis and cancer development. Here, we report that gain-of-function mutant p53 proteins inhibit the autophagic pathway favoring antiapoptotic effects as well as proliferation of pancreas and breast cancer cells. We found that mutant p53 significantly counteracts the formation of autophagic vesicles and their fusion with lysosomes throughout the repression of some key autophagy-related proteins and enzymes as BECN1 (and P-BECN1), DRAM1, ATG12, SESN1/2 and P-AMPK with the concomitant stimulation of mTOR signaling. As a paradigm of this mechanism, we show that atg12 gene repression was mediated by the recruitment of the p50 NF-κB/mutant p53 protein complex onto the atg12 promoter. Either mutant p53 or p50 NF-κB depletion downregulates atg12 gene expression. We further correlated the low expression levels of autophagic genes (atg12, becn1, sesn1, and dram1) with a reduced relapse free survival (RFS) and distant metastasis free survival (DMFS) of breast cancer patients carrying TP53 gene mutations conferring a prognostic value to this mutant p53-and autophagy-related signature. Interestingly, the mutant p53-driven mTOR stimulation sensitized cancer cells to the treatment with the mTOR inhibitor everolimus. All these results reveal a novel mechanism through which mutant p53 proteins promote cancer cell proliferation with the concomitant inhibition of autophagy.

AB - Mutations in TP53 gene play a pivotal role in tumorigenesis and cancer development. Here, we report that gain-of-function mutant p53 proteins inhibit the autophagic pathway favoring antiapoptotic effects as well as proliferation of pancreas and breast cancer cells. We found that mutant p53 significantly counteracts the formation of autophagic vesicles and their fusion with lysosomes throughout the repression of some key autophagy-related proteins and enzymes as BECN1 (and P-BECN1), DRAM1, ATG12, SESN1/2 and P-AMPK with the concomitant stimulation of mTOR signaling. As a paradigm of this mechanism, we show that atg12 gene repression was mediated by the recruitment of the p50 NF-κB/mutant p53 protein complex onto the atg12 promoter. Either mutant p53 or p50 NF-κB depletion downregulates atg12 gene expression. We further correlated the low expression levels of autophagic genes (atg12, becn1, sesn1, and dram1) with a reduced relapse free survival (RFS) and distant metastasis free survival (DMFS) of breast cancer patients carrying TP53 gene mutations conferring a prognostic value to this mutant p53-and autophagy-related signature. Interestingly, the mutant p53-driven mTOR stimulation sensitized cancer cells to the treatment with the mTOR inhibitor everolimus. All these results reveal a novel mechanism through which mutant p53 proteins promote cancer cell proliferation with the concomitant inhibition of autophagy.

KW - AMPK

KW - Autophagy

KW - Cancer

KW - Gain-of-function

KW - MTOR

KW - Mutant p53

UR - http://www.scopus.com/inward/record.url?scp=84963946049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963946049&partnerID=8YFLogxK

U2 - 10.1016/j.molonc.2016.04.001

DO - 10.1016/j.molonc.2016.04.001

M3 - Article

JO - Molecular Oncology

JF - Molecular Oncology

SN - 1574-7891

ER -